Allergan Bid For Device Firm Inamed Would Diversify Aesthetic Offerings
This article was originally published in The Pink Sheet Daily
Executive Summary
Purchase of Inamed would give Allergan entry into the facial aesthetics market and augment Allergan's Botox franchise. The $3.2 bil. offer for Inamed marks a $450 mil. premium over fellow bidder Medicis.